A novel inhibitor of respiratory syncytial virus isolated from ethnobotanicals
- 1 December 2005
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 68 (3) , 163-172
- https://doi.org/10.1016/j.antiviral.2005.09.003
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Antiviral activity and mode of action of caffeoylquinic acids from Schefflera heptaphylla (L.) FrodinAntiviral Research, 2005
- Orally Active Fusion Inhibitor of Respiratory Syncytial VirusAntimicrobial Agents and Chemotherapy, 2004
- An update on respiratory syncytial virus antiviral agentsExpert Opinion on Investigational Drugs, 2001
- Respiratory Syncytial Virus Infection in AdultsClinical Microbiology Reviews, 2000
- Nosocomial Respiratory Syncytial Virus Infections: Prevention and Control in Bone Marrow Transplant PatientsInfection Control & Hospital Epidemiology, 1997
- Respiratory Syncytial Virus Is an Important Cause of Community-Acquired Lower Respiratory Infection among Hospitalized AdultsThe Journal of Infectious Diseases, 1996
- Four Di-O-caffeoyl Quinic Acid Derivatives from Propolis. Potent Hepatoprotective Activity in Experimental Liver Injury Models.Biological & Pharmaceutical Bulletin, 1996
- Natural Product Drug Discovery and Development: New Perspectives on International CollaborationJournal of Natural Products, 1995
- The Application of Vacuum Liquid Chromatography to the Separation of Terpene MixturesJournal of Natural Products, 1986
- An outbreak of respiratory syncytial virus pneumonia in a nursing home for the elderlyJournal of Infection, 1984